 MOUNTAIN VIEW, Calif., March 24, 2021 PRNewswire -- Aditx Therapeutics, Inc. Aditxt the Company Nasdaq: ADTX, a biotech innovation company focused on improving the health of the immune system, today announced that its AditxtReprogrammingTM Therapeutics Division is preparing its therapeutic program for psoriasis for First-In-Human clinical trials. 